The DOI matches its Crossref record; 411 of the 411 references it cites were found in a registry or an index.
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Open accessAbstract
, and Enterobacterales. Polymyxins were first discovered in the late 1940s but were abandoned soon after their approval in the late 1950s as a result of toxicities (e.g., nephrotoxicity) and the availability of "safer" antibiotics approved at that time. Therefore, knowledge on polymyxins had been scarce until recently, when enormous efforts have been made by several research teams around the world to elucidate the chemical, microbiological, pharmacokinetic/pharmacodynamic, and toxicological properties of polymyxins. One of the major achievements is the development of the first scientifically based dosage regimens for colistin that are crucial to ensure its safe and effective use in patients. Although the guideline has not been developed for polymyxin B, a large clinical trial is currently being conducted to optimize its clinical use. Importantly, several novel, safer polymyxin-like lipopeptides are developed to overcome the nephrotoxicity, poor efficacy against pulmonary infections, and narrow therapeutic windows of the currently used polymyxin B and colistin. This review discusses the latest achievements on polymyxins and highlights the major challenges ahead in optimizing their clinical use and discovering new-generation polymyxins. To save lives from the deadly infections caused by Gram negative "superbugs," every effort must be made to improve the clinical utility of the last-line polymyxins. SIGNIFICANCE STATEMENT: Antimicrobial resistance poses a significant threat to global health. The increasing prevalence of multidrug-resistant (MDR) bacterial infections has been highlighted by leading global health organizations and authorities. Polymyxins are a last-line defense against difficult-to-treat MDR Gram negative pathogens. Unfortunately, the pharmacological information on polymyxins was very limited until recently. This review provides a comprehensive overview on the major achievements and challenges in polymyxin pharmacology and clinical use and how the recent findings have been employed to improve clinical practice worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics
Kohanski, M. A., Dwyer, D. J., Hayete, B., Lawrence, C. A., & Collins, J. J. (2007) · Cell · doi:10.1016/j.cell.2007.06.049 · Cited by 2,982
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Olaitan, A. O., Morand, S., & Rolain, J.-M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00643 · Cited by 1,395
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Self-citationTumbarello, M., Viale, P., Viscoli, C., Trecarichi, E. M., Tumietto, F., Marchese, A., Spanu, T., Ambretti, S., Ginocchio, F., Cristini, F., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis588 · Cited by 1,016
Tsuji, B. T., Pogue, J. M., Zavascki, A. P., Paul, M., Daikos, G. L., Forrest, A., Giacobbe, D. R., Viscoli, C., Giamarellou, H., Karaiskos, I., et al. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2209 · Cited by 949
Self-citationTrends in Infectious Disease Mortality in the United States During the 20th Century
Armstrong, G. L. (1999) · JAMA · doi:10.1001/jama.281.1.61 · Cited by 875
Cruz, D. N., Antonelli, M., Fumagalli, R., Foltran, F., Brienza, N., Donati, A., Malcangi, V., Petrini, F., Volta, G., Bobbio Pallavicini, F. M., et al. (2009) · JAMA · doi:10.1001/jama.2009.856 · Cited by 832
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Urinary Tract Infections: Disease Panorama and Challenges
Stamm, W. E., & Norrby, S. R. (2001) · The Journal of Infectious Diseases · doi:10.1086/318850 · Cited by 825
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides
Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819
Decontamination of the digestive tract and oropharynx in ICU patients
de Smet, A. M. G. A., Kluytmans, J. A. J. W., Cooper, B. S., Mascini, E. M., Benus, R. F. J., van der Werf, T. S., van der Hoeven, J. G., Pickkers, P., Bogaers-Hofman, D., van der Meer, N. J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800394 · Cited by 813
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Self-citationStructure−Activity Relationships of Polymyxin Antibiotics
Velkov, T., Thompson, P. E., Nation, R. L., & Li, J. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900999h · Cited by 780
Self-citationPolymyxin and Related Peptide Antibiotics
Storm, D. R., Rosenthal, K. S., & Swanson, P. E. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.003451 · Cited by 759
Goto, M., & Al-Hasan, M. N. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12195 · Cited by 752
Garonzik, S. M., Li, J., Thamlikitkul, V., Paterson, D. L., Shoham, S., Jacob, J., Silveira, F. P., Forrest, A., & Nation, R. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01733-10 · Cited by 696
Self-citationPaul, M., Daikos, G. L., Durante-Mangoni, E., Yahav, D., Carmeli, Y., Benattar, Y. D., Skiada, A., Andini, R., Eliakim-Raz, N., Nutman, A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30099-9 · Cited by 623
de Jonge, E., Schultz, M. J., Spanjaard, L., Bossuyt, P. M., Vroom, M. B., Dankert, J., & Kesecioglu, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14409-1 · Cited by 587
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Self-citationStructure of bacterial lipopolysaccharides
Caroff, M., & Karibian, D. (2003) · Carbohydrate Research · doi:10.1016/j.carres.2003.07.010 · Cited by 562
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Self-citationPolymyxin B Sulfate and Colistin: Old Antibiotics for Emerging Multiresistant Gram-Negative Bacteria
Evans, M. E., Feola, D. J., & Rapp, R. P. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18426 · Cited by 544
Expression cloning of a rat liver Na(+)-independent organic anion transporter.
Jacquemin, E., Hagenbuch, B., Stieger, B., Wolkoff, A. W., & Meier, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.133 · Cited by 535
Carattoli, A., Villa, L., Feudi, C., Curcio, L., Orsini, S., Luppi, A., Pezzotti, G., & Magistrali, C. F. (2017) · Eurosurveillance · doi:10.2807/1560-7917.es.2017.22.31.30589 · Cited by 533
Borowiak, M., Fischer, J., Hammerl, J. A., Hendriksen, R. S., Szabo, I., & Malorny, B. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx327 · Cited by 533
Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides
Campos, M. A., Vargas, M. A., Regueiro, V., Llompart, C. M., Albertí, S., & Bengoechea, J. A. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.7107-7114.2004 · Cited by 518
Dellinger, R. P., Bagshaw, S. M., Antonelli, M., Foster, D. M., Klein, D. J., Marshall, J. C., Palevsky, P. M., Weisberg, L. S., Schorr, C. A., Trzeciak, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.14618 · Cited by 502
Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
Dortet, L., Poirel, L., & Nordmann, P. (2014) · BioMed Research International · doi:10.1155/2014/249856 · Cited by 501
Plachouras, D., Karvanen, M., Friberg, L. E., Papadomichelakis, E., Antoniadou, A., Tsangaris, I., Karaiskos, I., Poulakou, G., Kontopidou, F., Armaganidis, A., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01361-08 · Cited by 494
An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane
Malinverni, J. C., & Silhavy, T. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903229106 · Cited by 491
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
Emergence of a novel mobile colistin resistance gene, mcr-8 , in NDM-producing Klebsiella pneumoniae
Wang, X., Wang, Y., Zhou, Y., Li, J., Yin, W., Wang, S., Zhang, S., Shen, J., Shen, Z., & Wang, Y. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0124-z · Cited by 460
Self-citationLuiten, E. J. T., Hop, W. C. J., Lange, J. F., & Bruining, H. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199507000-00010 · Cited by 457
Identification of novel mobile colistin resistance gene mcr-10
Wang, C., Feng, Y., Liu, L., Wei, L., Kang, M., & Zong, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1732231 · Cited by 456
Pharmacology of Polymyxins: New Insights into an ‘Old‘ Class of Antibiotics
Velkov, T., Roberts, K. D., Nation, R. L., Thompson, P. E., & Li, J. (2013) · Future Microbiology · doi:10.2217/fmb.13.39 · Cited by 452
Self-citationZarkotou, O., Pournaras, S., Tselioti, P., Dragoumanos, V., Pitiriga, V., Ranellou, K., Prekates, A., Themeli-Digalaki, K., & Tsakris, A. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03514.x · Cited by 438
Sandri, A. M., Landersdorfer, C. B., Jacob, J., Boniatti, M. M., Dalarosa, M. G., Falci, D. R., Behle, T. F., Bordinhão, R. C., Wang, J., Forrest, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit334 · Cited by 430
Self-citationMoskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Oral Decontamination with Chlorhexidine Reduces the Incidence of Ventilator-associated Pneumonia
Koeman, M., van der Ven, A. J. A. M., Hak, E., Joore, H. C. A., Kaasjager, K., de Smet, A. G. A., Ramsay, G., Dormans, T. P. J., Aarts, L. P. H. J., de Bel, E. E., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-820oc · Cited by 414
Molecular mechanisms of polymyxin resistance: knowns and unknowns
Baron, S., Hadjadj, L., Rolain, J.-M., & Olaitan, A. O. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.023 · Cited by 414
Neurotoxic effects associated with antibiotic use: management considerations
Grill, M. F., & Maganti, R. K. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03991.x · Cited by 410
The ABDOMIX Group, Payen, D. M., Guilhot, J., Launey, Y., Lukaszewicz, A. C., Kaaki, M., Veber, B., Pottecher, J., Joannes-Boyau, O., Martin-Lefevre, L., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3751-z · Cited by 407
Resistance to polymyxins in Gram-negative organisms
Jeannot, K., Bolard, A., & Plésiat, P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.11.029 · Cited by 402
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Qureshi, Z. A., Hittle, L. E., O'Hara, J. A., Rivera, J. I., Syed, A., Shields, R. K., Pasculle, A. W., Ernst, R. K., & Doi, Y. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ048 · Cited by 395
Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane Models
Clifton, L. A., Skoda, M. W. A., Le Brun, A. P., Ciesielski, F., Kuzmenko, I., Holt, S. A., & Lakey, J. H. (2015) · Langmuir · doi:10.1021/la504407v · Cited by 389
Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria
Bishop, R. E., Gibbons, H. S., Guina, T., Trent, M. S., Miller, S. I., & Raetz, C. R. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5071 · Cited by 388
Gales, A. C., Reis, A. O., & Jones, R. N. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.183-190.2001 · Cited by 382
Cannatelli, A., Giani, T., D'Andrea, M. M., Di Pilato, V., Arena, F., Conte, V., Tryfinopoulou, K., Vatopoulos, A., & Rossolini, G. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03110-14 · Cited by 374
Novel plasmid-mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae
Yang, Y.-Q., Li, Y.-X., Lei, C.-W., Zhang, A.-Y., & Wang, H.-N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky111 · Cited by 367
Colistin Methanesulfonate Is an Inactive Prodrug of Colistin against Pseudomonas aeruginosa
Bergen, P. J., Li, J., Rayner, C. R., & Nation, R. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00035-06 · Cited by 366
Self-citationcDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2
Okuda, M., Saito, H., Urakami, Y., Takano, M., & Inui, K.-I. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1056 · Cited by 352
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Cruz, D. N., Perazella, M. A., Bellomo, R., de Cal, M., Polanco, N., Corradi, V., Lentini, P., Nalesso, F., Ueno, T., Ranieri, V. M., et al. (2007) · Critical Care · doi:10.1186/cc5780 · Cited by 347
BERGMANS, D. C. J. J., BONTEN, M. J. M., GAILLARD, C. A., PALING, J. C., van der GEEST, S., van TIEL, F. H., BEYSENS, A. J., de LEEUW, P. W., & STOBBERINGH, E. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2005003 · Cited by 339
Gales, A. C., Jones, R. N., & Sader, H. S. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr239 · Cited by 337
Abe, T., Kakyo, M., Sakagami, H., Tokui, T., Nishio, T., Tanemoto, M., Nomura, H., Hebert, S. C., Matsuno, S., Kondo, H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22395 · Cited by 337
Trent, M. S., Ribeiro, A. A., Lin, S., Cotter, R. J., & Raetz, C. R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106961200 · Cited by 336
Lee, H., Hsu, F.-F., Turk, J., & Groisman, E. A. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.13.4124-4133.2004 · Cited by 334
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Gales, A. C., Castanheira, M., Jones, R. N., & Sader, H. S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.007 · Cited by 318
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Matuschek, E., Åhman, J., Webster, C., & Kahlmeter, G. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.11.020 · Cited by 311
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae
Poirel, L., Jayol, A., Bontron, S., Villegas, M.-V., Ozdamar, M., Turkoglu, S., & Nordmann, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku323 · Cited by 302
Krueger, W. A., Lenhart, F.-P., Neeser, G., Ruckdeschel, G., Schreckhase, H., Eissner, H.-J., Forst, H., Eckart, J., Peter, K., & Unertl, K. E. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2105141 · Cited by 299
Vincent, J.-L., Laterre, P.-F., Cohen, J., Burchardi, H., Bruining, H., Lerma, F. A., Wittebole, X., De Backer, D., Brett, S., Marzo, D., et al. (2005) · Shock · doi:10.1097/01.shk.0000159930.87737.8a · Cited by 297
Daneman, N., Sarwar, S., Fowler, R. A., & Cuthbertson, B. H. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70322-5 · Cited by 288
The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
Karaiskos, I., Lagou, S., Pontikis, K., Rapti, V., & Poulakou, G. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00151 · Cited by 288
AbuOun, M., Stubberfield, E. J., Duggett, N. A., Kirchner, M., Dormer, L., Nunez-Garcia, J., Randall, L. P., Lemma, F., Crook, D. W., Teale, C., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx286 · Cited by 282
Prevention of Ventilator-associated Pneumonia by Oral Decontamination
Ar, E., D-J, D., Jk, W., Riel, E., Df, N., Ca, C., Buysse, D., Ks, K., Berens, K. L., Hj, O., et al. (2001) · Cited by 281
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Cassir, N., Rolain, J.-M., & Brouqui, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00551 · Cited by 280
Arroyo, L. A., Herrera, C. M., Fernandez, L., Hankins, J. V., Trent, M. S., & Hancock, R. E. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00256-11 · Cited by 275
Antoniadou, A., Kontopidou, F., Poulakou, G., Koratzanis, E., Galani, I., Papadomichelakis, E., Kopterides, P., Souli, M., Armaganidis, A., & Giamarellou, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl562 · Cited by 273
Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection
Haworth, C. S., Foweraker, J. E., Wilkinson, P., Kenyon, R. F., & Bilton, D. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2208oc · Cited by 264
Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
Yu, Z., Qin, W., Lin, J., Fang, S., & Qiu, J. (2015) · BioMed Research International · doi:10.1155/2015/679109 · Cited by 263
Kox, L. F. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1861 · Cited by 263
Dosing guidance for intravenous colistin in critically-ill patients.
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw839 · Cited by 262
Self-citationKo, K. S., Suh, J. Y., Kwon, K. T., Jung, S.-I., Park, K.-H., Kang, C. I., Chung, D. R., Peck, K. R., & Song, J.-H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm305 · Cited by 262
The rise and spread of mcr plasmid-mediated polymyxin resistance
Nang, S. C., Li, J., & Velkov, T. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2018.1492902 · Cited by 255
Self-citationMacfarlane, E. L. A., Kwasnicka, A., Ochs, M. M., & Hancock, R. E. W. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01600.x · Cited by 254
Satlin, M. J., Lewis, J. S., Weinstein, M. P., Patel, J., Humphries, R. M., Kahlmeter, G., Giske, C. G., & Turnidge, J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa121 · Cited by 250
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis
Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 249
Prevention of colonization and infection in critically ill patients: A prospective randomized study
KERVER, A. J. H., ROMMES, J. H., MEVISSEN-VERHAGE, E. A. E., HULSTAERT, P. F., VOS, A., VERHOEF, J., & WITTEBOL, P. (1988) · Critical Care Medicine · doi:10.1097/00003246-198811000-00001 · Cited by 248
Dalfino, L., Puntillo, F., Mosca, A., Monno, R., Spada, M. L., Coppolecchia, S., Miragliotta, G., Bruno, F., & Brienza, N. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis286 · Cited by 247
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
Zhou, Q. (., Leung, S. S. Y., Tang, P., Parumasivam, T., Loh, Z. H., & Chan, H.-K. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.022 · Cited by 246
Self-citationKieffer, N., Royer, G., Decousser, J.-W., Bourrel, A.-S., Palmieri, M., Ortiz De La Rosa, J.-M., Jacquier, H., Denamur, E., Nordmann, P., & Poirel, L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00965-19 · Cited by 244
Lo-Ten-Foe, J. R., de Smet, A. M. G. A., Diederen, B. M. W., Kluytmans, J. A. J. W., & van Keulen, P. H. J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01406-06 · Cited by 242
Hindler, J. A., & Humphries, R. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03385-12 · Cited by 241
‘Aerosporin’, an Antibiotic Produced by Bacillus aerosporus Greer
Ainsworth, G. C., Brown, A. M., & Brownlee, G. G. (1947) · Nature · doi:10.1038/160263a0 · Cited by 239
Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
Zavascki, A. P., & Nation, R. L. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02319-16 · Cited by 239
Hengzhuang, W., Wu, H., Ciofu, O., Song, Z., & Høiby, N. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00126-11 · Cited by 238
Mohamed, A. F., Karaiskos, I., Plachouras, D., Karvanen, M., Pontikis, K., Jansson, B., Papadomichelakis, E., Antoniadou, A., Giamarellou, H., Armaganidis, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06426-11 · Cited by 234
Lipid A Modifications in Polymyxin-resistant Salmonella typhimurium
Zhou, Z., Ribeiro, A. A., Lin, S., Cotter, R. J., Miller, S. I., & Raetz, C. R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106960200 · Cited by 230
Betrosian, A. P., Frantzeskaki, F., Xanthaki, A., & Douzinas, E. E. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.002 · Cited by 230
Giddins, M. J., Macesic, N., Annavajhala, M. K., Stump, S., Khan, S., McConville, T. H., Mehta, M., Gomez-Simmonds, A., & Uhlemann, A.-C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-17 · Cited by 219
Wright, M. S., Suzuki, Y., Jones, M. B., Marshall, S. H., Rudin, S. D., van Duin, D., Kaye, K., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04037-14 · Cited by 216
Deris, Z. Z., Akter, J., Sivanesan, S., Roberts, K. D., Thompson, P. E., Nation, R. L., Li, J., & Velkov, T. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.111 · Cited by 216
Self-citationPugin, J., Auckenthaler, R., Lew, D. P., & Suter, P. M. (1991) · JAMA · doi:10.1001/jama.1991.03460200084041 · Cited by 213
Boisson, M., Jacobs, M., Grégoire, N., Gobin, P., Marchand, S., Couet, W., & Mimoz, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03510-14 · Cited by 211
Rattanaumpawan, P., Lorsutthitham, J., Ungprasert, P., Angkasekwinai, N., & Thamlikitkul, V. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq360 · Cited by 211
Chew, K. L., La, M.-V., Lin, R. T. P., & Teo, J. W. P. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00268-17 · Cited by 210
Schuster, A., Haliburn, C., Döring, G., Goldman, M. H., & for the Freedom Study Group (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202059 · Cited by 208
Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiber
Aoki, H., Kodama, M., Tani, T., & Hanasawa, K. (1994) · The American Journal of Surgery · doi:10.1016/0002-9610(94)90126-0 · Cited by 207
Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1
Busch, A. E., Quester, S., Ulzheimer, J. C., Waldegger, S., Gorboulev, V., Arndt, P., Lang, F., & Koepsell, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32599 · Cited by 206
Cheah, S.-E., Wang, J., Nguyen, V. T. T., Turnidge, J. D., Li, J., & Nation, R. L. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv267 · Cited by 206
Self-citationShen, H., Smith, D. E., Yang, T., Huang, Y. G., Schnermann, J. B., & Brosius, F. C. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f658 · Cited by 206
Sampson, T. R., Liu, X., Schroeder, M. R., Kraft, C. S., Burd, E. M., & Weiss, D. S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-12 · Cited by 205
Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa
Tam, V. H., Schilling, A. N., Vo, G., Kabbara, S., Kwa, A. L., Wiederhold, N. P., & Lewis, R. E. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3624-3630.2005 · Cited by 204
Jayol, A., Nordmann, P., Brink, A., & Poirel, L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05055-14 · Cited by 203
STOUTENBEEK, C. P., van SAENE, H. K. F., MIRANDA, D. R., F, D., & LANGREHR, D. (1987) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-198704000-00003 · Cited by 201
GARCÍA, M. S., CAMBRONERO GALACHE, J. A., DIAZ, J. L., CERDÁ, E. C., BLASCO, J. R., GÓMEZ AGUINAGA, M. A., REIZ, A. N., MARÍN, S. R., OÑORO CAÑAVERAL, J. J., & SACRISTÁN del CASTILLO, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9712079 · Cited by 199
Moffatt, J. H., Harper, M., Adler, B., Nation, R. L., Li, J., & Boyce, J. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01732-10 · Cited by 196
Self-citationVaara, M., Vaara, T., Jensen, M., Helander, I., Nurminen, M., Rietschel, E. T., & Mäkelä, P. H. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80777-6 · Cited by 195
Gordon, N. C., Png, K., & Wareham, D. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00922-10 · Cited by 195
Markou, N., Markantonis, S. L., Dimitrakis, E., Panidis, D., Boutzouka, E., Karatzas, S., Rafailidis, P., Apostolakos, H., & Baltopoulos, G. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.01.015 · Cited by 191
Kwa, A. L. H., Loh, C., Low, J. G. H., Kurup, A., & Tam, V. H. (2005) · Clinical Infectious Diseases · doi:10.1086/432583 · Cited by 191
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190
Emerging inhalation aerosol devices and strategies: Where are we headed?
Zhou, Q. (., Tang, P., Leung, S. S. Y., Chan, J. G. Y., & Chan, H.-K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.006 · Cited by 188
Self-citationNummila, K., Kilpeläinen, I., Zähringer, U., Vaara, M., & Helander, I. M. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02299.x · Cited by 186
Kaye, K. S., Pogue, J. M., Tran, T. B., Nation, R. L., & Li, J. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.005 · Cited by 186
Self-citationHengzhuang, W., Wu, H., Ciofu, O., Song, Z., & Høiby, N. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06486-11 · Cited by 185
Dai, C., Li, J., Tang, S., Li, J., & Xiao, X. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00070-14 · Cited by 185
Self-citationIn vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
Self-citationde Smet, A. M. G., Kluytmans, J. A., Blok, H. E., Mascini, E. M., Benus, R. F., Bernards, A. T., Kuijper, E. J., Leverstein-van Hall, M. A., Jansz, A. R., de Jongh, B. M., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70035-4 · Cited by 184
Colistin Heteroresistance in Acinetobacter and Its Association with Previous Colistin Therapy
Hawley, J. S., Murray, C. K., & Jorgensen, J. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-07 · Cited by 183
Halaby, T., al Naiemi, N., Kluytmans, J., van der Palen, J., & Vandenbroucke-Grauls, C. M. J. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02634-12 · Cited by 182
Henry, R., Vithanage, N., Harrison, P., Seemann, T., Coutts, S., Moffatt, J. H., Nation, R. L., Li, J., Harper, M., Adler, B., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05191-11 · Cited by 181
Self-citationBreazeale, S. D., Ribeiro, A. A., McClerren, A. L., & Raetz, C. R. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414265200 · Cited by 176
In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
Owen, R. J., Li, J., Nation, R. L., & Spelman, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl512 · Cited by 176
Self-citationRoberts, K. D., Azad, M. A. K., Wang, J., et al. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00085 · Cited by 173
Self-citationRODRIGUEZ-ROLDÁN, J. M., ALTUNA-CUESTA, A., LÓPEZ, A., CARRILLO, A., GARCIA, J., LEÓN, J., & MARTÍNEZ-PELLUS, A. J. (1990) · Critical Care Medicine · doi:10.1097/00003246-199011000-00011 · Cited by 172
Jones, R. N., Guzmán-Blanco, M., Gales, A. C., Gallegos, B., Castro, A. L. L., Martino, M. D. V., Vega, S., Zurita, J., Cepparulo, M., & Castanheira, M. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.07.002 · Cited by 171
Helander, I. M., Kilpeläinen, I., & Vaara, M. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00329.x · Cited by 170
Herrera, C. M., Hankins, J. V., & Trent, M. S. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07150.x · Cited by 170
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Yan, A., Guan, Z., & Raetz, C. R. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706172200 · Cited by 169
Cheng, H.-Y., Chen, Y.-F., & Peng, H.-L. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-60 · Cited by 166
Bergen, P. J., Bulitta, J. B., Forrest, A., Tsuji, B. T., Li, J., & Nation, R. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00903-09 · Cited by 166
Self-citationThe Vibrio cholerae ToxR-Regulated Porin OmpU Confers Resistance to Antimicrobial Peptides
Mathur, J., & Waldor, M. K. (2004) · Infection and Immunity · doi:10.1128/iai.72.6.3577-3583.2004 · Cited by 166
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Pournaras, S., Vrioni, G., Neou, E., Dendrinos, J., Dimitroulia, E., Poulou, A., & Tsakris, A. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.10.031 · Cited by 163
Receptor-Mediated Endocytosis in the Proximal Tubule
Gliozzi, M. L., & Weisz, O. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034234 · Cited by 163
Kidd, T. J., Mills, G., Sá‐Pessoa, J., Dumigan, A., Frank, C. G., Insua, J. L., Ingram, R., Hobley, L., & Bengoechea, J. A. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607336 · Cited by 163
Pharmacokinetics and pharmacodynamics of ‘old’ polymyxins: what is new?
Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., & Li, J. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.07.010 · Cited by 162
Self-citationW. S. Yapa, S., Li, J., Patel, K., Wilson, J. W., Dooley, M. J., George, J., Clark, D., Poole, S., Williams, E., Porter, C. J. H., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01705-13 · Cited by 161
Self-citationJohansen, H. K., Moskowitz, S. M., Ciofu, O., Pressler, T., & Høiby, N. (2008) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.02.003 · Cited by 161
Reynolds, C. M., Kalb, S. R., Cotter, R. J., & Raetz, C. R. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500964200 · Cited by 160
Gram-Negative Outer and Inner Membrane Models: Insertion of Cyclic Cationic Lipopeptides
Clausell, A., Garcia-Subirats, M., Pujol, M., Busquets, M. A., Rabanal, F., & Cajal, Y. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp064757+ · Cited by 159
Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy
Kubin, C. J., Ellman, T. M., Phadke, V., Haynes, L. J., Calfee, D. P., & Yin, M. T. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.01.015 · Cited by 158
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
Berlana, D., Llop, J. M., Casamartina, E. F., Badia, M., & Jódar, R. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.1.39 · Cited by 155
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality
Tumbarello, M., Repetto, E. C., Trecarichi, E. M., Bernardini, C., PASCALE, G. D., Parisini, A., Rossi, M., Molinari, M. P., Spanu, T., Viscoli, C., et al. (2011) · Epidemiology and Infection · doi:10.1017/s0950268810003055 · Cited by 155
Kallel, H., Hergafi, L., Bahloul, M., Hakim, A., Dammak, H., Chelly, H., Hamida, C. B., Chaari, A., Rekik, N., & Bouaziz, M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0675-2 · Cited by 154
Abele‐Horn, M., Dauber, A., Bauernfeind, A., Russwurm, W., Seyfarth-Metzger, I., Gleich, P., & Ruckdeschel, G. (1997) · Intensive Care Medicine · doi:10.1007/s001340050314 · Cited by 154
Falagas, M. E., Rafailidis, P. I., Matthaiou, D. K., Virtzili, S., Nikita, D., & Michalopoulos, A. S. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.05.016 · Cited by 154
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Bulitta, J. B., Yang, J. C., Yohonn, L., Ly, N. S., Brown, S. V., D'Hondt, R. E., Jusko, W. J., Forrest, A., & Tsuji, B. T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00881-09 · Cited by 152
Falagas, M. E., Bliziotis, I. A., & Tam, V. H. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.024 · Cited by 151
Zhanel, G. G., Adam, H. J., Baxter, M. R., Fuller, J., Nichol, K. A., Denisuik, A. J., Lagacé-Wiens, P. R. S., Walkty, A. J., Karlowsky, J. A., Schweizer, F., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt022 · Cited by 151
Rocha, L. Á., Martin, M. J., Pita, S., Paz, J., Seco, C., Margusino, L., Villanueva, R., & Durán-Valle, M. T. (1992) · Intensive Care Medicine · doi:10.1007/bf01694341 · Cited by 151
Hankins, J. V., Madsen, J. A., Giles, D. K., Brodbelt, J. S., & Trent, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201313109 · Cited by 150
Shoji, H., Tani, T., Hanasawa, K., & Kodama, M. (1998) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.1998.tb00066.x · Cited by 149
Tängdén, T., Hickman, R. A., Forsberg, P., Lagerbäck, P., Giske, C. G., & Cars, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00741-13 · Cited by 148
Abdellatif, S., Trifi, A., Daly, F., Mahjoub, K., Nasri, R., & Lakhal, S. B. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0127-7 · Cited by 148
Sobieszczyk, M. E. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh369 · Cited by 147
Yousef, J. M., Chen, G., Hill, P., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr483 · Cited by 147
Abdallah, M., Olafisoye, O., Cortes, C. D., Urban, C. M., Landman, D., & Quale, J. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04809-14 · Cited by 144
Fernández, L., Jenssen, H., Bains, M., Wiegand, I., Gooderham, W. J., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01530-12 · Cited by 143
Landersdorfer, C. B., Wang, J., Wirth, V., Chen, K., Kaye, K. S., Tsuji, B. T., Li, J., & Nation, R. L. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx409 · Cited by 143
Self-citationCockerill, F. R., Muller, S. R., Anhalt, J. P., Marsh, H. W., Farnell, M. B., Mucha, P., Gillespie, D. J., Ilstrup, D. M., Larson-Keller, J. J., & Thompson, R. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-7-545 · Cited by 142
Cheng, Y.-H., Lin, T., Lin, Y.-T., & Wang, J.-T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00009-16 · Cited by 142
Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity
Hori, Y., Aoki, N., Kuwahara, S., Hosojima, M., Kaseda, R., Goto, S., Iida, T., De, S., Kabasawa, H., Kaneko, R., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016060606 · Cited by 142
Bergen, P. J., Li, J., Nation, R. L., et al. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm511 · Cited by 140
Self-citationBuelow, E., Gonzalez, T. D. J. B., Fuentes, S., Piters, W. A. A. D. S., Lahti, L., Bayjanov, J. R., Majoor, E. A. M., Braat, J. C., van Mourik, M. S. M., Oostdijk, E. A. N., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0309-z · Cited by 140
Oxidative Decarboxylation of UDP-Glucuronic Acid in Extracts of Polymyxin-resistant Escherichia coli
Breazeale, S. D., Ribeiro, A. A., & Raetz, C. R. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109377200 · Cited by 139
Probing the Penetration of Antimicrobial Polymyxin Lipopeptides into Gram-Negative Bacteria
Deris, Z. Z., Swarbrick, J., Roberts, K. D., Azad, M. A. K., Akter, J., Horne, A. S., Nation, R. L., Rogers, K. L., Thompson, P. E., Velkov, T., et al. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500094d · Cited by 139
Self-citationTan, C.-H., Li, J., & Nation, R. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01571-06 · Cited by 138
Self-citationNovel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents
Vaara, M., Fox, J., Loidl, G., Siikanen, O., Apajalahti, J., Hansen, F., Frimodt‐Møller, N., Nagai, J., Takano, M., & Vaara, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00405-08 · Cited by 138
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
Vaara, M. (2019) · Molecules · doi:10.3390/molecules24020249 · Cited by 136
SODIUM SULPHOMETHYL DERIVATIVES OF POLYMYXINS
Barnett, M., Bushby, S. R. M., & Wilkinson, S. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01610.x · Cited by 134
Li, J., Rayner, C. R., Nation, R. L., Deans, R., Boots, R. J., Widdecombe, N., Douglas, A., & Lipman, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4814-4815.2005 · Cited by 133
Self-citationThe Role of Galectin-3 in the Kidneys
Chen, S., & Kuo, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040565 · Cited by 133
Satlin, M. J., Kubin, C. J., Blumenthal, J. S., Cohen, A. B., Furuya, E. Y., Wilson, S. J., Jenkins, S. G., & Calfee, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-11 · Cited by 132
Lübbert, C., Faucheux, S., Becker-Rux, D., Laudi, S., Dürrbeck, A., Busch, T., Gastmeier, P., Eckmanns, T., Rodloff, A. C., & Kaisers, U. X. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.008 · Cited by 132
Melatonin Attenuates Colistin-Induced Nephrotoxicity in Rats
Yousef, J. M., Chen, G., Hill, P., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00328-11 · Cited by 132
Gutu, A. D., Sgambati, N., Strasbourger, P., Brannon, M. K., Jacobs, M. A., Haugen, E., Kaul, R., Johansen, H. K., Høiby, N., & Moskowitz, S. M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02353-12 · Cited by 131
Clements, A., Tull, D., Jenney, A. W. J., Farn, J. L., Kim, S., Bishop, R. E., McPhee, J. B., Hancock, R. E. W., Hartland, E. L., Pearse, M. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701454200 · Cited by 130
Arroyo, L. A. R., García-Curiel, A., Pachón-Ibáñez, M. E., Llanos, A. C., Ruiz, M. T., Pachón, J., & Aznar, J. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.903-905.2005 · Cited by 130
Kuipers, M. T., van der Poll, T., Schultz, M. J., & Wieland, C. W. (2011) · Critical Care · doi:10.1186/cc10437 · Cited by 129
Role of Novel Multidrug Efflux Pump Involved in Drug Resistance in Klebsiella pneumoniae
Srinivasan, V. B., Singh, B. B., Priyadarshi, N., Chauhan, N. K., & Rajamohan, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096288 · Cited by 128
Bergen, P. J., Tsuji, B. T., Bulitta, J. B., Forrest, A., Jacob, J., Sidjabat, H. E., Paterson, D. L., Nation, R. L., & Li, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05298-11 · Cited by 128
Self-citation
Cited by
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health
Ding, L., Shen, S., Chen, J., Tian, Z., Shi, Q., Han, R., Guo, Y., & Hu, F. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-23 · Cited by 222
Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA
Oluwole, A. O., Kalmankar, N. V., Guida, M., Bennett, J. L., Poce, G., Bolla, J. R., & Robinson, C. V. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2408315121 · Cited by 13
Metadata
- Authors
- Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 73
- Issue
- 2
- Pages
- 679-728
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3131147063
- Cited by
- 421
- References
- 411
- FWCI
- 17.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.